Drug Database
Back to search

France· FR:64929099

REVESTIVE 5 mg, poudre et solvant pour solution injectable

A teduglutide product containing téduglutide, registered in France by TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE), on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC A16AX08

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedREVESTIVE 5 mg, poudre et solvant pou…ATCA16AX08REGISTER NO.FR:64929099PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about téduglutideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Teduglutide is registered in 15 of 19 countries.

Countries holding a registration under ATC A16AX08 (teduglutide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 9 of them publish a price we can compare per daily dose
Search teduglutide products by name

Teduglutide · ATC A16AX08

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TÉDUGLUTIDE
Manufacturer
TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
Country
France (FR)
ATC code
A16AX08
ATC class
Teduglutide
Defined daily dose
5 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

1 priced
  • cip13
    3400927722097
    28 flacon(s) en verre - 28 seringue(s) préremplie(s) en verre de 0,5 ml avec 6 piston(s)
    EUR 6.61
  • cip13
    3400930078617
    1 flacon(s) en verre - 1 seringue(s) préremplie(s) en verre de 0,5 ml avec piston(s)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

18 interactions on record for teduglutide.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check teduglutide against other medicinesHow interaction checks work

Teduglutide · interactions on record

18 records

  • 2 severe
  • 16 moderate

Most severe, free to view

  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • ClonazepamN03AE01moderate
  • MidazolamN03AE02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Teduglutide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All teduglutide products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Austria · Tidonalle
  • Spain · Teduglutida Cipla
  • Iceland · Revestive, Teduglutide Viatris
  • Liechtenstein · Revestive, Teduglutide Viatris
  • Norway · Niletto, Revestive
  • Sweden · Nilleto, Teduglutid Cipla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d1e7c9db-4995-4b33-970a-d2c7a3872092
GET /v1/drugs/d1e7c9db-4995-4b33-970a-d2c7a3872092?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64929099",
  "date_amm": "2012-08-30",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/12/787",
  "substance": "TÉDUGLUTIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour solution injectable",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}
API referenceMCP serverPlans

See everything about teduglutide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console